Evidence map›Paper›PMID 23561053›Full record

ArticleMicrobial cell factories2013

Oral immunization with Lactococcus lactis secreting attenuated recombinant staphylococcal enterotoxin B induces a protective immune response in a murine model.

Giselli Fernandes Asensi, Nathalia Ferrari Fonseca de Sales, Fabiano Ferreira Dutra, Daniel Ferreira Feijó, Marcelo Torres Bozza, Robert G Ulrich, Anderson Miyoshi, Katia de Morais, Vasco Ariston de Carvalho Azevedo, Joab Trajano Silva and 2 more

Open access · goldAbstract read
In one paragraph

Article in Microbial cell factories, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Journal of microbiology and biotechnology · 2025
    Pooled it
  2. Review
  3. Review
  4. Review
  5. Toxins · 2021
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Recombinant-attenuatedJournal of veterinary science · 2018
    Article
  14. Article
  15. Article
  16. Article
  17. Development ofVaccines · 2014
    Article
  18. Avicenna journal of medical biotechnology
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Giselli Fernandes AsensiUniversidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Nathalia Ferrari Fonseca de Sales
Fabiano Ferreira Dutra
Daniel Ferreira Feijó
Marcelo Torres Bozza
Robert G Ulrich
Anderson Miyoshi
Katia de Morais
Vasco Ariston de Carvalho Azevedo
Joab Trajano Silva
Yves Le Loir
Vânia Margaret Flosi Paschoalin
Universidade do Estado do Rio de Janeiro · BRUniversidade Federal de Minas Gerais · BRInstitut Agro Rennes-Angers · FRUnited States Army Medical Research Institute of Infectious Diseases · USUniversidade Federal do Rio de Janeiro · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStaphylococcus aureus is unrestrictedly found in humans and in animal species that maintain thermal homeostasis. Inadequate cleaning of processing equipment or inappropriate handling can contaminate processed food and cause severe food poisoning. Staphylococcal enterotoxin B (SEB), a potent superantigenic exotoxin, is produced by 50% of clinical isolates of S. aureus and is associated with massive food poisoning and with the induction of toxic shock syndrome.

resultsA gene sequence encoding a recombinant SEB (rSEB), devoid of superantigenic activity, was successfully cloned and expressed in a cytoplasmic or a secreted form in the food-grade lactic acid bacterium Lactococcus lactis. The recombinant protein detected in the cytoplasm or in the culture medium exhibited the expected molecular mass and was recognized by a SEB-polyclonal antibody. Oral immunization with the recombinant L. lactis strains induced a protective immune response in a murine model of S. aureus infection. Immunized mice survived intraperitoneal challenge with an S. aureus SEB-producer strain. Counts of S. aureus in the spleen of rSEB-immunized mice were significantly reduced. The rSEB-immunized mice showed significant titers of anti-SEB IgA and IgG in stools and serum, respectively. Both recombinant L. lactis strains were able to elicit cellular or systemic immune responses in mice, with no significant difference if rSEB was produced in its cytoplasmic or secreted form. However, recombinant L. lactis expressing the cytoplasmic rSEB increased the survival rate of the challenged mice by 43%.

conclusionsThese findings show the vaccine efficacy of L. lactis carrying an attenuated SEB, in a murine model, following lethal S. aureus challenge.

Indexed as

Administration, OralAnimalsAntibodiesEnterotoxinsLactococcus lactisMiceMice, Inbred C57BLModels, AnimalProtein EngineeringRecombinant ProteinsVaccines, SyntheticAntibodiesenterotoxin B, staphylococcalEnterotoxinsRecombinant ProteinsVaccines, Synthetic

Identifiers

PMID23561053
PMCPMC3623888
OpenAlexW2116786816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.